CVS Health (CVS) posted better-than-expected results on gains in its health services business, but shares fell 1% in early trading Wednesday as the big pharmacy chain reduced its unadjusted profit guidance.

CVS reported third quarter fiscal 2023 澳洲幸运5开奖号码历史查询:earnings per share (EPS) of $2.21, with revenue increasing 10.6% year-over-year to $89.76 billion. Both exceeded forecasts.

Sales at its Health Services segment were up 8.4% to $48.89 billion, boosted by its pharmacy drug mix, growth in specialty pharmacy, brand inflation, and the acquisitions earlier this year of 澳洲幸运5开奖号码历史查询:Oak Street Health, which offers primary care to senior citizens, and in-home healthcare provider Signify Health. Revenue at its Health Care Benefits division added 16.9% to $26.30 billion with growth along🦄 all its product lines.

The company noted that a drop in demand for COVID-19 vaccines and a change in a Medicaid customer contracts contributed to a decline in pharmacy claim꧟s.

The report is the second since CVS launched a 澳洲幸运5开奖号码历史查询:major restructuring, which it said was intended to “streamline and simplify the o♑rganization, improve efficiency, and reduce costs.ꦿ” 

CVS reduced its unadjusted full-year EPS to $6.37 to $6.61, down from the previous estimate of $6.ꦫ53 to $6.75. ꧑It kept its adjusted EPS outlook at $8.50 to $8.70.

Shares of CVS traded near their lows for the year early in the session Wednesday before recovering somewhat, although they remained in the red. They're down more than 25% in 2023.